How a pharma giant made pain sufferers spend more

By Esther Han
Updated December 30 2017 - 9:53am, first published December 7 2017 - 9:20am

Two pharma giants have been taken to the Federal Court for allegedly misleading osteoarthritis sufferers into paying 33 per cent more for a "more effective" product that offers "targeted relief", when this was not the case.